United States · FDA National Drug Code directory
COSELA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73462-101_fd1c99c8-df20-4278-b963-603bb0c10715
- Product NDC
- 73462-101
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- trilaciclib
- Labeler
- G1 Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210212 / 20281231
Source-listed ingredients
- TRILACICLIB DIHYDROCHLORIDE — 300 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (73462-101-01) / 20 mL in 1 VIAL, GLASS · 73462-101-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →